In vivo response of Plasmodium falciparum to chloroquine in pregnant and non-pregnant women in Siaya District, Kenya.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMC 2491082)

Published in Bull World Health Organ on January 01, 1987

Authors

R W Steketee, A D Brandling-Bennett, D C Kaseje, I K Schwartz, F C Churchill

Articles by these authors

HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health (2001) 6.29

Effect of blood transfusion on survival among children in a Kenyan hospital. Lancet (1992) 4.32

Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg (1998) 3.74

The opportunity and obligation to eliminate measles from the United States. JAMA (1979) 2.93

Effectiveness of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in western Kenya: a hospital-based study. Trop Med Int Health (2004) 2.33

Drug therapy for Plasmodium falciparum malaria resistant to pyrimethamine-sulfadoxine (Fansidar). A study of alternate regimens in Eastern Thailand, 1980. Lancet (1981) 2.32

Amodiaquine as a prodrug: importance of metabolite(s) in the antimalarial effect of amodiaquine in humans. Life Sci (1985) 2.21

The reservoir of Plasmodium falciparum malaria in a holoendemic area of western Kenya. Trans R Soc Trop Med Hyg (1992) 2.20

Prospective assessment of mortality among a cohort of pregnant women in rural Malawi. Am J Trop Med Hyg (1996) 2.10

Babesiosis in Wisconsin. A new focus of disease transmission. JAMA (1985) 2.06

The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg (1994) 2.05

Analysis of filter-paper-absorbed, finger-stick blood samples for chloroquine and its major metabolite using high-performance liquid chromatography with fluorescence detection. J Chromatogr (1983) 1.99

Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria. Lancet (2001) 1.85

In-hospital morbidity and mortality due to malaria-associated severe anaemia in two areas of Malawi with different patterns of malaria infection. Trans R Soc Trop Med Hyg (1995) 1.78

Epidemic cholera in the Americas. Science (1992) 1.72

Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting. JAMA (1996) 1.64

Permethrin-impregnated curtains and bed-nets prevent malaria in western Kenya. Am J Trop Med Hyg (1990) 1.59

An evaluation of clinical indicators for severe paediatric illness. Bull World Health Organ (1996) 1.57

Rubella vaccination in the United States: a ten-year review. Epidemiol Rev (1980) 1.53

Infectious diseases in Latin America and the Caribbean: are they really emerging and increasing? Emerg Infect Dis (1996) 1.52

Risk of congenital abnormality after inadvertent rubella vaccination of pregnant women. N Engl J Med (1976) 1.50

Risk factors for HIV infection among asymptomatic pregnant women attending an antenatal clinic in western Kenya. Int J STD AIDS (2000) 1.46

Chloroquine-resistant Plasmodium vivax from Indonesia. N Engl J Med (1991) 1.46

Genetic evaluation of suspected cases of transient HIV-1 infection of infants. Science (1998) 1.43

Longitudinal evaluation of severely anemic children in Kenya: the effect of transfusion on mortality and hematologic recovery. AIDS (1997) 1.32

Measles prevention and control in emergency settings. Bull World Health Organ (1989) 1.30

Treatment of malaria fever episodes among children in Malawi: results of a KAP survey. Trop Med Parasitol (1994) 1.28

In-vivo and in-vitro assessment of chloroquine-resistant Plasmodium falciparum malaria in Zanzibar. Lancet (1983) 1.27

Identification of malaria species by ELISA in sporozoite and oocyst infected Anopheles from western Kenya. Am J Trop Med Hyg (1988) 1.25

Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group. J Infect Dis (1998) 1.22

Chloroquine treatment of severe malaria in children. Pharmacokinetics, toxicity, and new dosage recommendations. N Engl J Med (1988) 1.22

Rates and risk factors for mortality during the first two years of life in rural Malawi. Am J Trop Med Hyg (1996) 1.21

Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection. AIDS (1995) 1.21

Malaria and childbearing women in Malawi: knowledge, attitudes and practices. Trop Med Parasitol (1994) 1.20

Distinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children. Perinatal AIDS Collaborative Transmission Study. J Infect Dis (1999) 1.20

Malaria incidence and prevention among European and North American travellers to Kenya. Bull World Health Organ (1990) 1.19

Community-based malaria control in Saradidi, Kenya: description of the programme and impact on parasitaemia rates and antimalarial antibodies. Ann Trop Med Parasitol (1987) 1.16

Antibody response to preexposure human diploid-cell rabies vaccine given concurrently with chloroquine. N Engl J Med (1986) 1.16

Response of children with Plasmodium falciparum to chloroquine and development of a national malaria treatment policy in Zaire. Trans R Soc Trop Med Hyg (1988) 1.14

Mefloquine therapy for Plasmodium falciparum malaria in children under 5 years of age in Malawi: in vivo/in vitro efficacy and correlation of drug concentration with parasitological outcome. Bull World Health Organ (1990) 1.14

Malaria infection in infancy in rural Malawi. Am J Trop Med Hyg (1996) 1.12

Indications for the use of Fansidar in malaria. N Engl J Med (1982) 1.12

Rapid spontaneous postpartum clearance of Plasmodium falciparum parasitaemia in African women. Lancet (1988) 1.11

Adaptations of the Saker-Solomons test: simple, reliable colorimetric field assays for chloroquine and its metabolites in urine. Bull World Health Organ (1989) 1.11

The effect of maternal viral load on the risk of perinatal transmission of HIV-1. New York City Perinatal HIV Transmission Collaborative Study Group. AIDS (1997) 1.10

Sensitivity and specificity of a qualitative RNA detection assay to diagnose HIV infection in young infants. Perinatal AIDS Collaborative Transmission Study. AIDS (1998) 1.09

The effect of placental malaria infection on perinatal mortality in rural Malawi. Am J Trop Med Hyg (1996) 1.09

Cost-effectiveness of sulfadoxine-pyrimethamine for the prevention of malaria-associated low birth weight. Am J Trop Med Hyg (2001) 1.08

Susceptibility of Plasmodium falciparum to pyrimethamine and sulfadoxine/pyrimethamine in Kisumu, Kenya. Lancet (1982) 1.08

Evaluation of maternal practices, efficacy, and cost-effectiveness of alternative antimalarial regimens for use in pregnancy: chloroquine and sulfadoxine-pyrimethamine. Am J Trop Med Hyg (1996) 1.08

Risk factors for anemia in young children in rural Malawi. Am J Trop Med Hyg (1994) 1.07

Impact on mortality and fertility of a community-based malaria control programme in Saradidi, Kenya. Ann Trop Med Parasitol (1987) 1.07

Timing of maternal-infant HIV transmission: associations between intrapartum factors and early polymerase chain reaction results. New York City Perinatal HIV Transmission Collaborative Study Group. AIDS (1997) 1.07

Antenatal chloroquine chemoprophylaxis in Malawi: chloroquine resistance, compliance, protective efficacy and cost. Trans R Soc Trop Med Hyg (1991) 1.06

Detection of antibodies in human sera to the repeating epitope of the circumsporozoite protein of Plasmodium falciparum using the synthetic peptide (NANP)3 in an enzyme-linked immunosorbent assay (ELISA). Am J Trop Med Hyg (1987) 1.06

Inadequacy of chlorproguanil 20 mg per week as chemoprophylaxis for falciparum malaria in Kenya. Lancet (1987) 1.06

Effect of maternal CD4+ cell count, acquired immunodeficiency syndrome, and viral load on disease progression in infants with perinatally acquired human immunodeficiency virus type 1 infection. New York City Perinatal HIV Transmission Collaborative Study Group. J Pediatr (1997) 1.05

Assessment of exposure to organophosphate insecticides during spraying in Haiti: monitoring of urinary metabolites and blood cholinesterase levels. Bull World Health Organ (1985) 1.03

Use of malaria prevention measures in Malawian households. Trop Med Parasitol (1994) 1.02

Surveillance of the congenital rubella syndrome, 1969-1973. J Infect Dis (1974) 1.02

Consumption of chloroquine phosphate provided for treatment of malaria by volunteer village health workers in Saradidi, Kenya. Ann Trop Med Parasitol (1987) 1.02

Chlorproguanil/dapsone for the treatment of non-severe Plasmodium falciparum malaria in Kenya: a pilot study. Trans R Soc Trop Med Hyg (1988) 1.02

Infant and second-year mortality in rural Malawi: causes and descriptive epidemiology. Am J Trop Med Hyg (1996) 1.01

Evaluation of amodiaquine treatment of chloroquine-resistant Plasmodium falciparum malaria on Zanzibar, 1982. Am J Trop Med Hyg (1983) 1.01

Vector density, parasite prevalence, and transmission of Onchocerca volvulus in Guatemala. Am J Trop Med Hyg (1988) 1.01

Changes in sources of treatment occurring after inception of a community-based malaria control programme in Saradidi, Kenya. Ann Trop Med Parasitol (1987) 1.00

Onchocerciasis in Guatemala. Epidemiology in fincas with various intensities of infection. Am J Trop Med Hyg (1981) 1.00

Transplacental transmission of Plasmodium falciparum in rural Malawi. Am J Trop Med Hyg (1996) 0.99

In vitro susceptibility of Plasmodium falciparum isolates from Jilore, Kenya, to antimalarial drugs. Am J Trop Med Hyg (1987) 0.99

Amodiaquine more effective than chloroquine against Plasmodium falciparum malaria on Kenya coast. Lancet (1984) 0.99

Isolation, characterization and standardization of a major metabolite of amodiaquine by chromatographic and spectroscopic methods. J Chromatogr (1986) 0.98

Vitamin A deficiency and maternal-infant transmissions of HIV in two metropolitan areas in the United States. AIDS (1997) 0.96

Antimalarials during pregnancy: a cost-effectiveness analysis. Bull World Health Organ (1995) 0.96

Comparison of chloroquine, pyrimethamine and sulfadoxine, and chlorproguanil and dapsone as treatment for falciparum malaria in pregnant and non-pregnant women, Kakamega District, Kenya. BMJ (1990) 0.95

Comparison of DNA probe and cytogenetic methods for identifying field collected Anopheles gambiae complex mosquitoes. Am J Trop Med Hyg (1988) 0.95

Malaria surveillance--United States, 1998. MMWR CDC Surveill Summ (2001) 0.95

Antibodies to Plasmodium falciparum ring-infected erythrocyte surface antigen and P. falciparum and P. malariae circumsporozoite proteins: seasonal prevalence in Kenyan villages. Am J Trop Med Hyg (1989) 0.95

Neutralizing antibody and perinatal transmission of human immunodeficiency virus type 1. New York City Perinatal HIV Transmission Collaborative Study Group. AIDS Res Hum Retroviruses (1998) 0.95

Chloroquine-resistant falciparum malaria. N Engl J Med (1983) 0.95

Time course of radiometric detection of positive blood cultures in childhood. Pediatr Infect Dis (1986) 0.94

Colorimetric and thin-layer chromatographic methods for field assay of chloroquine and its metabolites in urine. Bull World Health Organ (1987) 0.93

Malaria chemoprophylaxis to pregnant women provided by community health workers in Saradidi, Kenya. II. Effect on parasitaemia and haemoglobin levels. Ann Trop Med Parasitol (1987) 0.92

High-performance liquid chromatographic assay for the simultaneous monitoring of mefloquine and its acid metabolite in biological samples using protein precipitation and ion-pair extraction. J Chromatogr (1988) 0.92

Glucose-6-phosphate dehydrogenase deficiency in Southeast Asian refugees entering the United States. Am J Trop Med Hyg (1984) 0.91

Growth of civil society in developing countries: implications for health. Lancet (1998) 0.90

A review of five years' experience with rubella vaccine in the United States. Pediatrics (1975) 0.90

Plasmodium falciparum infection rates in Anopheles gambiae, An. arabiensis, and An. funestus in western Kenya. Am J Trop Med Hyg (1990) 0.90

Recent trends in the importation of malaria caused by Plasmodium falciparum into the United States from Africa. J Infect Dis (1985) 0.90

Microgeographic variation in rDNA intergenic spacers of Anopheles gambiae in western Kenya. Heredity (Edinb) (1989) 0.89

Sensitive analysis of blood for amodiaquine and three metabolites by high-performance liquid chromatography with electrochemical detection. J Chromatogr (1986) 0.89

Field application of a colorimetric method of assaying chloroquine and desethylchloroquine in urine. Bull World Health Organ (1988) 0.88

Confirmation that Plasmodium falciparum has aperiodic infectivity to Anopheles gambiae. Med Vet Entomol (1993) 0.88

Assessment of a synthetic DNA probe for Plasmodium falciparum in African blood specimens. Am J Trop Med Hyg (1987) 0.88